Previous Close
$3.4
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$354.3 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the ...
Community
- 0 posts discussing
0
Watchers
0
Visitors